SFA Therapeutics, Inc.
Microbiome
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as drugs.
Most popular related searches
chronic inflammatory disease
cytokine storm
autoimmune disease
treatment of inflammatory disease
carcinoma hcc
COVID 19
liver disease
microbiome
chronic inflammatory
hepatitis B
Clinical Development
Autoimmune Diseases: Psoriasis
Infectious Disease: Cytokine Storm in COVID-19, Sepsis, Viral infection.
Discovery
Liver Diseases: Hepatitis B, Steatosis, NASH, NAFLD
Dermatology: Bullous Pemphigus (Rare Autoimmune Disease)
Ophthalmology: Uveitis
Oncology: Liver Cancer, Hepatocellular Carcinoma (HCC), Prevention of Cytokine Storm in CAR T Therapy.